Geranial is the sharper lemon-smelling E-isomer within the broader citral family and appears in multiple AromaForge citrus and citral-rich oils, including lemon myrtle, distilled lemon, bergamot, lime, and lemon verbena records. The source-grounded evidence is strongest for identity, isomer chemistry, antimicrobial and antifungal screening, and contact-allergy relevance. Preclinical anti-inflammatory signals do exist, but the current literature still supports describing geranial mainly as a high-impact lemon aldehyde with meaningful safety context rather than a clinically validated standalone active.
Chemical identity and composition
NIST identifies geranial as 2,6-octadienal, 3,7-dimethyl-, (E)- with formula C10H16O and InChIKey WTEVQBCEXWBHNA-JXMROGBWSA-N. PubChem synonym data map geranial, trans-citral, alpha-citral, and citral A onto the broader citral record, reflecting the common trade practice of treating geranial as one of the two principal citral isomers.
Aroma and practical use
- Use the recorded strong lemon, citrusy, fresh, aldehydic, sharp, citrus, sharp lemon, bright descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2021 antifungal study reported that geranial was more potent than neral against Trichophyton rubrum and that both isomers inhibited ergosterol biosynthesis in the fungus.
This is one of the clearest constituent-specific comparisons because it isolates the two citral isomers rather than treating citral only as a mixture.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2009 food-microbiology study found that isolated geranial and neral showed marked antifungal effects against multiple fungi from legume seeds and inhibited aflatoxin B1 production by Aspergillus flavus isolates.
This supports archive language around preservative-style antimicrobial research while remaining clearly non-clinical.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2014 immunology paper reported that geranial and citral showed significant in vivo anti-allergic and anti-inflammatory effects in mouse passive cutaneous anaphylaxis and ear-edema models after the investigators identified lemongrass oil as the strongest EO in their screening set.
The paper is useful because it tests geranial itself, but it remains preclinical and should not be translated into disease-treatment claims.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2019 dermatitis-patient patch-test study reported positive reactions to geranial in 3.4% of 1476 tested patients and concluded that geranial and neral, although closely related, are separate haptens.
This is unusually direct human evidence for safety relevance and is more important to the archive than speculative benefit language.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
A mechanistic autoxidation paper found that geranial forms 6,7-epoxygeranial and a dioxolane hydroperoxide, with the latter and 6,7-epoxygeranial identified as strong sensitizers responsible for air-exposed geranial's skin-sensitization potency.
This is one of the strongest mechanistic explanations for why geranial deserves explicit oxidation-aware safety notes.
This experimental finding does not establish benefit, dose or safety in people using this blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedGeranial has direct patch-test evidence as a human fragrance allergen and was concluded in one dermatitis study to be a separate hapten from neral.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
No direct public citation is attached to this entry.
Air exposure and oxidation matter: mechanistic studies identify reactive oxidation products from geranial itself, including strong sensitizers.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
Most positive activity literature for isolated geranial is still in-vitro or animal-based, so archive copy should avoid implying established human therapeutic use.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
NeralAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
animal · effect
No source citation attached.
Read Neral report →LimoneneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Limonene report →EugenolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Eugenol report →CarvacrolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Carvacrol report →citronellalAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read citronellal report →CuminaldehydeAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Cuminaldehyde report →(E)-cinnamaldehydeAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read (E)-cinnamaldehyde report →How the effects were investigated
fungal_ergosterol_biosynthesis_interference
An antifungal isomer-comparison study reported that geranial and neral inhibited ergosterol biosynthesis in Trichophyton rubrum, with geranial showing greater potency in the tested system.
This experimental finding does not establish benefit, dose or safety in people using this blend.
autoxidation_to_reactive_sensitizers
Autoxidation work found geranial forms reactive products including 6,7-epoxygeranial and a dioxolane hydroperoxide identified as strong skin sensitizers, explaining why geranial has direct contact-allergy relevance.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- This pass did not verify a strong isolated human clinical efficacy literature for geranial apart from allergy-focused data.
- PubChem identity records commonly collapse geranial into the broader citral entry, so source interpretation requires distinguishing the isomer from the mixture manually.
- A directly readable public dermal concentration limit specific to isolated geranial was not confirmed in this pass.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.